Emergent Product Development Germany GmbH

Emergent BioSolutions is a biopharmaceutical company focused on the development, manufacture and commercialization of immunobiotics. Immunobiotics are pharmaceutical products, such as vaccines and immune globulins, that induce or assist the body’s immune system to prevent or treat disease. We operate in two business segments: biodefense and commercial. In our biodefense business, we develop and commercialize immunobiotics for use against biological agents that are potential weapons of bioterrorism. In our commercial business, we develop immunobiotics for use against infectious diseases with significant unmet or underserved medical needs.

Details


Adresse:
Emergent Product Development Germany GmbH

Am Klopferspitz 19
82152 Martinsried
Deutschland
Arbeitsgebiet:
Forschung & Lehre
Expansion:
international
Mitarbeiteranzahl:
51-500